Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Cosmoplat coordinates $155m series B

China Life has boosted the industrial internet-of-things specialist in its quest to deliver the advantages of industry 4.0.


Sep 3, 2021

Cue Health chooses Nasdaq Global Market for IPO

Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.

Sep 3, 2021

Disc Medicine injects $90m in series B

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

Sep 3, 2021

Corelight concentrates $75m into series D

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Osage University Partners.

Sep 3, 2021

Corelight concentrates $75m into series D

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Capital One and CrowdStrike.

Sep 3, 2021

Xerox creates CareAR

Xerox’s newly formed augmented reality software business has been valued at $700m through an investment by ServiceNow.

Sep 3, 2021

Humane harnesses $100m in series B

Humane aims to deliver “the next shift between humans and computing” with series B funding from investors including Qualcomm and SoftBank.

Sep 3, 2021

Jeeves adds $57m series B

Stanford-backed expense management platform Jeeves has received series B funding, two months after emerging from stealth.

Sep 3, 2021

Carsome collects $170m in series D2

Automotive e-commerce platform Carsome has reached a $1.3bn valuation through the close of a series D2 round backed by Catcha Group, MediaTek, MUFG Innovation Partners and Daiwa PI Partners.

Sep 2, 2021

VanMoof gets $128m in series C

Sinbon Electronics-backed VanMoof has accumulated $182m of total funding following a series C round.

Sep 2, 2021

Asher Bio targeted with $108m series B

Alexandria Venture Investments is among the investors supporting the immunotherapy developer focused on cancer, autoimmune and infectious diseases.

Sep 2, 2021

Daily deal net: September 2, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 2, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here